Beneficios de los inhibidores de la dipeptidil peptidasa-4 frente a otros hipoglucemiantes orales | Zendy

AI Assistant Blog Pricing

Open Access

Beneficios de los inhibidores de la dipeptidil peptidasa-4 frente a otros hipoglucemiantes orales

Author(s) -

Katya Cecilia Hernández González,

Luis Daniel Navarro Aparicio

Publication year - 2022

Publication title -

lux médica

Language(s) - Spanish

Resource type - Journals

eISSN - 2007-8714

pISSN - 2007-1655

DOI - 10.33064/51lm20223196

Subject(s) - medicine , humanities , philosophy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.